The Ripples technology originated at Prof. Shlomo Magdassi’s lab at the Hebrew University of Jerusalem, was licensed-out by Yissum, the technology transfer company of the Hebrew University, and was brought to market with seed funding from Landa Ventures.
HumanEyes was founded by Yissum and Professor Shmuel Peleg, from the School of Engineering and Computer Science of The Hebrew University of Jerusalem.
CollPlant is a clinical stage regenerative Medicine Company focused on developing and commercializing tissue repair products, initially for orthobiologics and advanced wound care markets. Our products are based on our rhCollagen (recombinant human collagen) that is produced with CollPlant’s proprietary plant based genetic engineering technology.
Yissum's start up Betalin Therapeutics is developing an engineered micro-pancreas (EMP) that can sustain significant levels of glucose-regulated insulin secretion from transplanted beta cells.
They are at the heart of every electronic device. Yet the way printed circuit boards, or PCBs, are made, hasn't changed in decades. Enter Israeli startup Nano Dimension. It's looking to disrupt this 100 billion-dollar market with an all-new 3D printer.
Enter AB103, a rationally designed short peptide that modulates the inflammatory response by binding to the CD28 dimer interface. Ness Ziona, Israel-based Atox has just launched the phase III study called ACCUTE, a rough acronym for "AB103 Clinical Composite endpoint StUdy in necrotizing soft Tissue InfEctions." Conducted at 40 centers in the U.S., the experiment will enroll 290 patients given round-the-clock support and treatment. Data should be available by the end of 2017.
Within the next 24 months, the Israeli company NanoLock expects to win regulatory clearance for its first two products embedded with a novel antimicrobial nanomaterial developed in the lab of Prof. Ervin Weiss, former head of prosthodontics at the Hebrew University Hadassah School of Dental Medicine in Jerusalem and current dean of the Tel Aviv University dental school.Within the next 24 months, the Israeli company NanoLock expects to win regulatory clearance for its first two products embedded with a novel antimicrobial nanomaterial developed in the lab of Prof. Ervin Weiss, former head of prosthodontics at the Hebrew University Hadassah School of Dental Medicine in Jerusalem and current dean of the Tel Aviv University dental school.
YIssum's startup Betaline Therapeutics is currently in pre clinical studies.
Yissum's startup Briefcam creates video synopsis of important events of survailance camera footage.
Betalin Therapeutics strives to cure diabetes by a single transplant of its proprietary Engineered Micro Pancreas (EMP), that provides significant levels of glucose-regulated insulin secretion over extended periods of time. The company was established in 2015, based on technology developed at the lab of Prof. Eduardo Mitrani from Department of Cell and Developmental Biology at the Hebrew University of Jerusalem and was licensed under an exclusive worldwide agreement with Yissum, the technology transfer office of the Hebrew University.
Hebrew University’s Yissum tech transfer company sets out to commercialize local innovative agricultural technologies
Nano Dimension’s novel and proprietary technologies enable the use of conductive ink for ultra-rapid prototyping of complex, high-performance, multilayer printed circuit boards. The company’s DragonFly 2020 3D PCB printer is the result of combining technological breakthroughs in inkjets, 3D printing and nanotechnology. The new patented system is capable of switching between three different modes: inkjet, cleaning, and suction, which allow it to maintain a stable temperature, facilitate cleaning, and make it possible to recycle the ink into the main tank for reuse.
Agrinnovation announced today the closing of a U.S. $4.0 million first round of financing. The round of investment was led by the Victor Smorgon Group from Australia. Other investors include Yissum and the Provident Fund of the Employees of the Hebrew University of Jerusalem. In the upcoming days, a group of Chinese-Israeli investors will also join the fund, which is expected to raise a total of up to U.S. $6.0 million. The funds raised will be used to advance agritech technologies and to the establishment of new agricultural start-ups.
Agrinnovation said Monday it raised $4 million in a round of funding led by Victor Smorgon Groupfrom Australia. Other investors include Yissum Research Development Company and theProvident Fund of the Employees of the Hebrew University of Jerusalem. Agrinnovation is an investment fund focused on agricultural inventions. The fund said a group of Chinese-Israeli investors will also likely invest, boosting total funding to $6 million.
HIPPY, or Home Instruction for Parents of Preschool Youngsters, is designed to help low-income parents prepare their 3- to 5-year-old children to start school. Parents receive a weekly curriculum. They are given books on a schedule — every week or every other week — including a new book that teaches them how to become their child’s first teacher.
The program was started in Israel in 1969 to help immigrants from North Africa and the Middle East prepare for life in their new country. HIPPY, which still operates in its native country, came to the United States in 1980 via the National Council for Jewish Women’s Research Institute for Innovation in Education at the Hebrew University of Jerusalem.
The Hebrew University of Jerusalem, Israel’s premier university and leading research institution, and the Fraunhofer Institute for Secure Information Technology SIT, the leading institute for applied cybersecurity research in Germany, agreed to jointly create a Fraunhofer Project Center for Cybersecurity in Jerusalem. The planned center is meant to become the leading institution for applied cybersecurity research in Israel, as well as worldwide.
A patented, highly efficient and environmentally responsible nanoparticle synthesis process enables the unique properties of AgCite inks. The process is licensed through inks pioneer Professor Shlomo Magdassi and Yissum Research Development Company, the technology transfer company of the Hebrew University of Jerusalem. The nanoparticle synthesis process begins with a silver precursor raw material and allows for fine control of the size, shape and distribution of the silver nanoparticles in accordance with customers’ printing requirements. This nanoparticle synthesis process is critical to the types of nanoparticles and ink formulations that can be produced.
Nano Dimension, a leading printing electronics company in the area of 3D printing (TASE: NNDM, OTCQB: NNDMY), announced today that Nano Dimension Technologies, a fully owned subsidiary of Nano Dimension, has made its first sale of 3D printers and nano inks in India, totaling USD $250K. The transaction was completed by Vigilante Environmental Solutions, Nano Dimension's business developer in India.
Yissum's Avraham Pharma shows promising new data on the long way to finding cure.
Dana Gavish Fridman, VP of marketing, joins VOI's Simcha Gluck to talk about the Hebrew University's 'tech transfer' company.
Dana explains how her company works: collecting ideas and intellectual property from the professors and researchers at the Hebrew University in Jerusalem and then patenting, funding research and development, and monetizing them. Generating more than $2 billion in annual sales, it has developed 2,500 inventions — from cherry tomatoes to cancer drugs to Mobileye, Israel’s most profitable innovation so far — and has 9,000 patents. Dana talks about what it’s like to work with the country’s greatest minds, and shares some little-known facts about the role that Israel’s Chief Scientist plays on the innovation scene.